SPRO Stock Summary and Trading Ideas (Spero Therapeutics | NASDAQ:SPRO)

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. Besides, it is also focused on SPR206, a next-generation polymyxin investigational product candidate, being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.

Spero Therapeutics trades on the NASDAQ stock market under the symbol SPRO.

As of May 15, 2024, SPRO stock price climbed to $1.62 with 99,040 million shares trading.

SPRO has a beta of 1.45, meaning it tends to be more sensitive to market movements. SPRO has a correlation of 0.12 to the broad based SPY ETF.

SPRO has a market cap of $87.27 million. This is considered a Micro Cap stock.

Last quarter Spero Therapeutics reported $74 million in Revenue and $.96 earnings per share. This beat revenue expectation by $55 million and exceeded earnings estimates by $1.06.

In the last 3 years, SPRO stock traded as high as $19.87 and as low as $.68.

The top ETF exchange traded funds that SPRO belongs to (by Net Assets): VTI, VXF, IWC, AVSC.

SPRO stock has underperformed the market in the last year with a return of -12.4%, while SPY returned +30.1%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in SPRO shares. However, SPRO has outperformed the market in the last 3 month and 2 week periods, returning +9.8% and +14.1%, while SPY returned +6.4% and +5.3%, respectively. This indicates SPRO has been having a stronger performance recently.

SPRO support price is $1.55 and resistance is $1.66 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SPRO stock will trade within this expected range on the day.